Alaunos Therapeutics Inc (NAS:TCRT)
$ 1.06 -0.01 (-0.93%) Market Cap: 16.97 Mil Enterprise Value: 11.07 Mil PE Ratio: 0 PB Ratio: 3.53 GF Score: 38/100

Q4 2018 ZIOPHARM Oncology Inc Earnings Call Transcript

Mar 05, 2019 / 09:30PM GMT
Release Date Price: $44.25 (+8.86%)
Operator

Good day, ladies and gentlemen, and welcome to the Ziopharm Fourth Quarter 2018 Earnings Call. (Operator Instructions). As a reminder, today's program may be recorded.

I would now like to introduce your host for today's program, David Connolly, Vice President of Corporate Communications and Investor Relations. Please go ahead.

David Connolly
ZIOPHARM Oncology, Inc. - VP of Corporate Communications & IR

Hi. Thank you. We're starting a few minutes late this afternoon as there was a last minute rush of callers. We wanted to give a few minutes to let folks actually get engaged on the call. And earlier today, we issued a press release with our financial results for the fourth quarter and the year-end of 2018, and that press release is available on our website, www.ziopharm.com.

We'll discuss these results today and company highlights during this call, and representatives of the company will make a number of forward-looking statements that are -- including statements regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot